Bruker Corp BRKR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Bruker Reports Third Quarter 2026 Financial Results
Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast
Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley
Bruker Corporation to Present at Upcoming Investor Conferences
BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion
Trading Information
- Previous Close Price
- $62.24
- Day Range
- $62.56–64.09
- 52-Week Range
- $32.38–68.86
- Bid/Ask
- $62.79 / $63.05
- Shares Outstanding
- 152.72M
- Market Cap
- $9.57B
- Volume/Avg
- 141,120 / 2M
Key Statistics
- Price/Earnings (Normalized)
- 33.83
- Price/Sales
- 2.70
- Dividend Yield (Trailing)
- 0.32%
- Dividend Yield (Forward)
- 0.32%
- Dividend Payment Schedule
- Jan, Apr, Jul, Oct
- Total Yield
- 0.32%
Company Profile
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 11,085
- Website
- https://www.bruker.com
Valuation
Metric | BRKR |
|---|---|
Price/Earnings (Normalized) | 33.83 |
Price/Book Value | 4.16 |
Price/Sales | 2.70 |
Price/Cash Flow | 20.96 |
Price/Earnings
BRKR
Financial Strength
Metric | BRKR |
|---|---|
Quick Ratio | 0.82 |
Current Ratio | 1.84 |
Interest Coverage | −0.76 |
Quick Ratio
BRKR
Profitability
Metric | BRKR |
|---|---|
Return on Assets (Normalized) | 5.06% |
Return on Equity (Normalized) | 12.95% |
Return on Invested Capital (Normalized) | 7.70% |
Return on Assets
BRKR
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|%>%NGzX | LOCK|?#P>& | $191B | |||
| Medtronic PLC MDT | LOCK|^#<#dq | LOCK|Yw!$ | $130B | |||
| Stryker Corp SYK | LOCK|%^JVKqM | LOCK|&M? | $123B | |||
| Boston Scientific Corp BSX | LOCK|m%D%dW@ | LOCK|!&^n@ | $65B | |||
| Edwards Lifesciences Corp EW | LOCK|Vx^L?!>p | LOCK|@%%? | $60B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|CZT%FR$ | LOCK|#L | $38B | |||
| DexCom Inc DXCM | LOCK|$zXw^$tR | LOCK|pV#Y | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|jw@ | LOCK|XsT | $30B | |||
| Steris PLC STE | LOCK|>P?&%HS | LOCK|l#N>@ | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|r&x<!&R> | LOCK|?!< | $20B |
United States